Search
for
Sort by
Research 301–330 of 1000+
- Conceptual Basis for Use of Chemotherapeutic Agents and Their Pharmacology
- An In Situ Chemotherapy Drug Combined with Immune Checkpoint Inhibitor for Chemoimmunotherapy
- Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression
- Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going
- Systems for Mitochondria-Protective Cosmetic Actives: Opportunities in Post-Oncologic Skin Regeneration
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- Cytokines
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers
- Trastuzumab Induced Chemobrain, Atorvastatin Rescued Chemobrain with Enhanced Anticancer Effect and without Hair Loss-Side Effect
- A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- The Carcinogenesis of the Human Scalp: An Immunometabolic-Centered View
- Reporting on Adverse Clinical Events
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Advances in clinical applications of microneedle
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Cutaneous reactions to recombinant cytokine therapy
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Quiescent Tissue Stem Cells Evade Immune Surveillance
- Lysophospholipid Mediators in Health and Disease
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Dermatologic Reactions to Targeted Therapy
- Loss of the Y Chromosome: A Review of Molecular Mechanisms, Age Inference, and Implications for Men’s Health
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Melatonin/Chitosan Biomaterials for Wound Healing and Beyond: A Multifunctional Therapeutic Approach
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- Aesthetic medicine treatments for oncology patients — a narrative literature review